This report contains market size and forecasts of Antivirals in global, including the following market information:
Global Antivirals Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Antivirals Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Antivirals companies in 2020 (%)
The global Antivirals market was valued at 45910 million in 2020 and is projected to reach US$ 54350 million by 2027, at a CAGR of 4.3% during the forecast period.
Publisher has surveyed the Antivirals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antivirals Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Antivirals Market Segment Percentages, By Type, 2020 (%)
Generic
Branded
Global Antivirals Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Antivirals Market Segment Percentages, By Application, 2020 (%)
HIV
Hepatitis
HSV
Influenza
Global Antivirals Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Antivirals Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antivirals revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Antivirals revenues share in global market, 2020 (%)
Key companies Antivirals sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Antivirals sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy's
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antivirals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antivirals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antivirals Overall Market Size
2.1 Global Antivirals Market Size: 2021 VS 2027
2.2 Global Antivirals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Antivirals Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Antivirals Players in Global Market
3.2 Top Global Antivirals Companies Ranked by Revenue
3.3 Global Antivirals Revenue by Companies
3.4 Global Antivirals Sales by Companies
3.5 Global Antivirals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antivirals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Antivirals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antivirals Players in Global Market
3.8.1 List of Global Tier 1 Antivirals Companies
3.8.2 List of Global Tier 2 and Tier 3 Antivirals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antivirals Market Size Markets, 2021 & 2027
4.1.2 Generic
4.1.3 Branded
4.2 By Type - Global Antivirals Revenue & Forecasts
4.2.1 By Type - Global Antivirals Revenue, 2016-2021
4.2.2 By Type - Global Antivirals Revenue, 2022-2027
4.2.3 By Type - Global Antivirals Revenue Market Share, 2016-2027
4.3 By Type - Global Antivirals Sales & Forecasts
4.3.1 By Type - Global Antivirals Sales, 2016-2021
4.3.2 By Type - Global Antivirals Sales, 2022-2027
4.3.3 By Type - Global Antivirals Sales Market Share, 2016-2027
4.4 By Type - Global Antivirals Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antivirals Market Size, 2021 & 2027
5.1.2 HIV
5.1.3 Hepatitis
5.1.4 HSV
5.1.5 Influenza
5.2 By Application - Global Antivirals Revenue & Forecasts
5.2.1 By Application - Global Antivirals Revenue, 2016-2021
5.2.2 By Application - Global Antivirals Revenue, 2022-2027
5.2.3 By Application - Global Antivirals Revenue Market Share, 2016-2027
5.3 By Application - Global Antivirals Sales & Forecasts
5.3.1 By Application - Global Antivirals Sales, 2016-2021
5.3.2 By Application - Global Antivirals Sales, 2022-2027
5.3.3 By Application - Global Antivirals Sales Market Share, 2016-2027
5.4 By Application - Global Antivirals Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Antivirals Market Size, 2021 & 2027
6.2 By Region - Global Antivirals Revenue & Forecasts
6.2.1 By Region - Global Antivirals Revenue, 2016-2021
6.2.2 By Region - Global Antivirals Revenue, 2022-2027
6.2.3 By Region - Global Antivirals Revenue Market Share, 2016-2027
6.3 By Region - Global Antivirals Sales & Forecasts
6.3.1 By Region - Global Antivirals Sales, 2016-2021
6.3.2 By Region - Global Antivirals Sales, 2022-2027
6.3.3 By Region - Global Antivirals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Antivirals Revenue, 2016-2027
6.4.2 By Country - North America Antivirals Sales, 2016-2027
6.4.3 US Antivirals Market Size, 2016-2027
6.4.4 Canada Antivirals Market Size, 2016-2027
6.4.5 Mexico Antivirals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Antivirals Revenue, 2016-2027
6.5.2 By Country - Europe Antivirals Sales, 2016-2027
6.5.3 Germany Antivirals Market Size, 2016-2027
6.5.4 France Antivirals Market Size, 2016-2027
6.5.5 U.K. Antivirals Market Size, 2016-2027
6.5.6 Italy Antivirals Market Size, 2016-2027
6.5.7 Russia Antivirals Market Size, 2016-2027
6.5.8 Nordic Countries Antivirals Market Size, 2016-2027
6.5.9 Benelux Antivirals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Antivirals Revenue, 2016-2027
6.6.2 By Region - Asia Antivirals Sales, 2016-2027
6.6.3 China Antivirals Market Size, 2016-2027
6.6.4 Japan Antivirals Market Size, 2016-2027
6.6.5 South Korea Antivirals Market Size, 2016-2027
6.6.6 Southeast Asia Antivirals Market Size, 2016-2027
6.6.7 India Antivirals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Antivirals Revenue, 2016-2027
6.7.2 By Country - South America Antivirals Sales, 2016-2027
6.7.3 Brazil Antivirals Market Size, 2016-2027
6.7.4 Argentina Antivirals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antivirals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Antivirals Sales, 2016-2027
6.8.3 Turkey Antivirals Market Size, 2016-2027
6.8.4 Israel Antivirals Market Size, 2016-2027
6.8.5 Saudi Arabia Antivirals Market Size, 2016-2027
6.8.6 UAE Antivirals Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Antivirals Major Product Offerings
7.1.4 Merck Antivirals Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antivirals Major Product Offerings
7.2.4 Johnson & Johnson Antivirals Sales and Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Antivirals Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Antivirals Sales and Revenue in Global (2016-2021)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Antivirals Major Product Offerings
7.4.4 GSK Antivirals Sales and Revenue in Global (2016-2021)
7.4.5 GSK Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Antivirals Major Product Offerings
7.5.4 Mylan Antivirals Sales and Revenue in Global (2016-2021)
7.5.5 Mylan Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Antivirals Major Product Offerings
7.6.4 Gilead Sciences Antivirals Sales and Revenue in Global (2016-2021)
7.6.5 Gilead Sciences Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Antivirals Major Product Offerings
7.4.4 F. Hoffmann-La Roche Antivirals Sales and Revenue in Global (2016-2021)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Bristol-Myers-Squibb
7.8.1 Bristol-Myers-Squibb Corporate Summary
7.8.2 Bristol-Myers-Squibb Business Overview
7.8.3 Bristol-Myers-Squibb Antivirals Major Product Offerings
7.8.4 Bristol-Myers-Squibb Antivirals Sales and Revenue in Global (2016-2021)
7.8.5 Bristol-Myers-Squibb Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Antivirals Major Product Offerings
7.9.4 AbbVie Antivirals Sales and Revenue in Global (2016-2021)
7.9.5 AbbVie Key News
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Corporate Summary
7.10.2 Aurobindo Pharma Business Overview
7.10.3 Aurobindo Pharma Antivirals Major Product Offerings
7.10.4 Aurobindo Pharma Antivirals Sales and Revenue in Global (2016-2021)
7.10.5 Aurobindo Pharma Key News
7.11 Cipla
7.11.1 Cipla Corporate Summary
7.11.2 Cipla Antivirals Business Overview
7.11.3 Cipla Antivirals Major Product Offerings
7.11.4 Cipla Antivirals Sales and Revenue in Global (2016-2021)
7.11.5 Cipla Key News
7.12 Dr Reddy
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy's